No Data
No Data
Australian Clinical Labs Started With A$3.20/Share Target Price by Ord Minnett>ACL.AU
Australian Clinical Labs Started With A$3.20/Share Target Price by Ord Minnett>ACL.AU
Australian Clinical Labs Started at Buy by Ord Minnett >ACL.AU
Australian Clinical Labs Started at Buy by Ord Minnett >ACL.AU
Ord Minnett Starts Australian Clinical Labs at Buy, Price Target Is AU$3.50
07:43 PM EDT, 05/27/2024 (MT Newswires) -- Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50 Price (AUD): $2.21, Change: $, Percent Change: %
3 ASX 300 Shares Hitting New 52-week Lows: Are They Cheap Buys?
The Australian share market may be trading near its record high but that hasn't stopped some ASX 300 shares from hitting new 52-week lows.
Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast
Australian Clinical Labs (ASX:ACL) has reaffirmed its fiscal 2024 guidance range, expecting underlying earnings before interest and taxes (EBIT) to fall in the lower of its previously disclosed AU$60
Australian Clinical Labs Ltd: FY24 Trading Update
No Data